This is a discussion on Alpharma withdraws painkiller NDA within the Biotechnology News forum, part of the Industry News and Updates category; Alpharma has withdrawn its NDA for Embeda, its extended-release painkiller. While the company's drug qualified for priority review, ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
|
|||
|
Alpharma has withdrawn its NDA for Embeda, its extended-release painkiller. While the company's drug qualified for priority review, Alpharma said that "certain technical issues around data Read more...
More... |